Business Standard

Beryl Drugs Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018 FOR THE QUARTER...Read More05/07/2024
Closure of Trading Window Closure of Trading window30/06/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication NEWSPAPER PUBLICATION31/05/2024
Board Meeting Intimation for Adoption Of Audited Accounts BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of t...Read More22/05/2024
Board Meeting Outcome for OUTCOME OF BOARD MEETING OUTCOME OF BOARD MEETING20/04/2024
COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 31.03.2024 COMPLIANCE CERTIFICATE17/04/2024
Declaration As Per Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26.11.2018 Regarding Large Entity Or Large Corporate. NON APPLICABILITY CERTIFICATE: BERYL DRUGS IS NOT IDENTIFIED AS LARGE ENTITY13/04/2024
Compliances-Reg.24(A)-Annual Secretarial Compliance NON APPLICABILITY CERTIFICATE13/04/2024
Board Meeting Intimation for To Take Note Of General Disclosures Of Interest Of Directors Under Section 184 (1) In Form MBP-1 For The Year Ended 2024-2025 BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of t...Read More12/04/2024
Compliance-57 (5) : intimation after the end of quarter NON APPLICABILITY CERTIFICATE FOR THE QUARTER ENDED 31.03.202405/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 COMPLIANCE CERTIFICATE UNDER REGULATION 74(5) FOR THE QUARTER ENDED 31.03.202405/04/2024
COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) FOR THE QUARTER ENDED 31.03.2024 COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) FOR THE QUARTER ENDED 31.03.202405/04/2024
Closure of Trading Window INTIMATION OF CLOSURE OF TRADING WINDOW28/03/2024
UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER 2023 UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER 202312/02/2024
Board Meeting Outcome for OUTCOME OF BOARD MEETING OUTCOME OF BOARD MEETING12/02/2024
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Result Of The Company For The Quarter Ended 31St December2O23 BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of t...Read More01/02/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter...Read More06/01/2024
Compliance-57 (5) : intimation after the end of quarter COMPLIANCE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 31ST DECEMBER 202306/01/2024
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Result Of The Company For The Quarter Ended 30Th June 2023. BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of t...Read More03/08/2023
Compliance-57 (5) : intimation after the end of quarter NON APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH ...Read More10/07/2023

Load more